Published in Bone on September 01, 1997
Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats. PLoS One (2016) 1.39
Potent antiarthritic properties of a glucocorticoid derivative, NCX-1015, in an experimental model of arthritis. Proc Natl Acad Sci U S A (2002) 0.97
Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss. J Clin Endocrinol Metab (2009) 0.93
Retracted Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 0.83
Evaluating glucocorticoid administration on biomechanical properties of rats' tibial diaphysis. Iran Red Crescent Med J (2015) 0.81
Concern The effects of organic nitrates on osteoporosis: a systematic review. Osteoporos Int (2013) 0.79
Organic nitrate maintains bone marrow blood perfusion in ovariectomized female rats: a dynamic, contrast-enhanced magnetic resonance imaging (MRI) study. Pharmaceutics (2012) 0.79
The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747]. Trials (2006) 0.78
Dietary arginine silicate inositol complex increased bone healing: histologic and histomorphometric study. Drug Des Devel Ther (2016) 0.76
Supraphysiologic glucocorticoid administration increased biomechanical bone strength of rats' vertebral body. Lab Anim Res (2015) 0.75
Dietary arginine silicate inositol complex inhibits periodontal tissue loss in rats with ligature-induced periodontitis. Drug Des Devel Ther (2016) 0.75
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78
Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science (2001) 8.12
X-ray structure determination of fully hydrated L alpha phase dipalmitoylphosphatidylcholine bilayers. Biophys J (1996) 5.60
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest (2000) 4.36
Survival by time of day of hemodialysis in an elderly cohort. JAMA (2001) 4.09
Measurement of chain tilt angle in fully hydrated bilayers of gel phase lecithins. Biophys J (1993) 4.08
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology (2001) 3.25
The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science (1999) 3.23
Relationship of a putative receptor protein kinase from maize to the S-locus glycoproteins of Brassica. Nature (1990) 3.11
Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68
Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators. J Med Chem (1995) 2.68
Synthetic nano-scale fibrous extracellular matrix. J Biomed Mater Res (1999) 2.21
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci U S A (2001) 1.92
Atomic resolution imaging of a carbon nanotube from diffraction intensities. Science (2003) 1.90
Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. Nat Struct Biol (2000) 1.89
Cytokinin Biochemistry in Relation to Leaf Senescence: IV. Cytokinin Metabolism in Soybean Explants. Plant Physiol (1988) 1.87
Lung cancer among Chinese women. Int J Cancer (1987) 1.83
Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population. Diabetologia (2009) 1.83
Purified N-cadherin is a potent substrate for the rapid induction of neurite outgrowth. J Cell Biol (1990) 1.82
Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue. Nature (1975) 1.80
Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev Biol (1996) 1.75
Analysis of distribution of bases in the coding sequences by a diagrammatic technique. Nucleic Acids Res (1991) 1.75
Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy. Circ Res (2000) 1.72
Identification of a minimal hydrophobic domain in the herpes simplex virus type 1 scaffolding protein which is required for interaction with the major capsid protein. J Virol (1996) 1.56
Engineering new bone tissue in vitro on highly porous poly(alpha-hydroxyl acids)/hydroxyapatite composite scaffolds. J Biomed Mater Res (2001) 1.55
Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo. Circ Res (1999) 1.54
Perspectives on the new kidney disease education benefit: early awareness, race and kidney transplant access in a USRDS study. Am J Transplant (2012) 1.51
Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. J Biol Chem (2000) 1.51
Comparison of the free and DNA-complexed forms of the DNA-binding domain from c-Myb. Nat Struct Biol (1995) 1.46
Rhythmic dentinogenesis in the rabbit incisor: allometric aspects. Calcif Tissue Int (1980) 1.45
Application of analytical and preparative high-speed counter-current chromatography for separation of alkaloids from Coptis chinensis Franch. J Chromatogr A (1998) 1.42
A picoliter-volume mixer for microfluidic analytical systems. Anal Chem (2001) 1.38
Microtubular architecture of biodegradable polymer scaffolds. J Biomed Mater Res (2001) 1.38
Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies. Proc Natl Acad Sci U S A (1997) 1.35
Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ Res (1996) 1.34
Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. Clin Cancer Res (1996) 1.31
Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Proc Natl Acad Sci U S A (1998) 1.30
The crystal structure of a high oxygen affinity species of haemoglobin (bar-headed goose haemoglobin in the oxy form). J Mol Biol (1996) 1.30
A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity. J Antibiot (Tokyo) (1988) 1.28
Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation. Proc Natl Acad Sci U S A (2000) 1.25
Tissue-specific expression of mRNA encoding rat kidney water channel CHIP28k by in situ hybridization. Am J Physiol (1993) 1.24
White matter integrity in physically fit older adults. Neuroimage (2013) 1.23
Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapy. Clin Cancer Res (1998) 1.21
Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Joint Surg Am (2000) 1.21
Biochemical characterization and crystal structure determination of human heart short chain L-3-hydroxyacyl-CoA dehydrogenase provide insights into catalytic mechanism. Biochemistry (1999) 1.21
20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action. Br J Cancer (2008) 1.21
Ca(2+) channel modulation by recombinant auxiliary beta subunits expressed in young adult heart cells. Circ Res (2000) 1.20
Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population. Diabetologia (2009) 1.20
Improving promoter prediction for the NNPP2.2 algorithm: a case study using Escherichia coli DNA sequences. Bioinformatics (2004) 1.19
Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets. Drug Dev Ind Pharm (2000) 1.19
Characterization of insulinlike growth factor I receptors in human colon cancer. Gastroenterology (1992) 1.18
Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy. Clin Pharmacol Ther (1995) 1.17
A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood (1991) 1.17
A novel method to calculate the G+C content of genomic DNA sequences. J Biomol Struct Dyn (2001) 1.17
Relationship between plasma D(-)-lactate and intestinal damage after severe injuries in rats. World J Gastroenterol (2001) 1.15
hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas. Oncogene (2011) 1.14
Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I. J Biol Chem (1997) 1.14
Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility. Public Health (2005) 1.14
Formation of bone by isolated, cultured osteoblasts in millipore diffusion chambers. Calcif Tissue Int (1982) 1.13
Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals. Cancer Lett (1997) 1.13
Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol (1995) 1.13
A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population. Diabetologia (2008) 1.13
Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro. Am J Pathol (1997) 1.13
Comparative phylogeography of five avian species: implications for Pleistocene evolutionary history in the Qinghai-Tibetan plateau. Mol Ecol (2009) 1.13
Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms. Clin Cancer Res (2001) 1.12
3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord (2006) 1.12
An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53. Gene Ther (2002) 1.11
Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone (1996) 1.11
Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR. J Pathol (2008) 1.11
Our experience on management of Boerhaave's syndrome with late presentation. Dis Esophagus (2008) 1.11
Modeling of nonlinear physiological systems with fast and slow dynamics. II. Application to cerebral autoregulation. Ann Biomed Eng (2002) 1.10
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J Virol (2000) 1.10
Differential screening of gene expression difference enriched by differential display. Nucleic Acids Res (1996) 1.10
Functional analyses of the mutation nt-128 T→G in the hepatocyte nuclear factor-1α promoter region in Chinese diabetes pedigrees. Diabet Med (2012) 1.09
Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. Proc Natl Acad Sci U S A (1999) 1.09
Presynaptic adrenergic facilitation of parasympathetic neurotransmission in sympathectomized rat smooth muscle. J Physiol (1998) 1.09
Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia (2013) 1.07
Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex. Biochemistry (1998) 1.07
The characteristics of rhizosphere microbes associated with plants in arsenic-contaminated soils from cattle dip sites. Sci Total Environ (2007) 1.07
Population-based and family-based association studies of ZNF804A locus and schizophrenia. Mol Psychiatry (2010) 1.06
Observation of a charged charmoniumlike structure in e+ e- → π+ π- J/ψ at sqrt[s] = 4.26 GeV. Phys Rev Lett (2013) 1.05
Fracture healing perspectives. Clin Orthop Relat Res (1985) 1.05
Chondrocyte-to-osteocyte transformation in grafts of perichondrium-free epiphyseal cartilage. Clin Orthop Relat Res (1978) 1.05
Comparative morphology of the marrow sac. Anat Rec (2000) 1.04
Pre-eclampsia-like conditions produced by nitric oxide inhibition: effects of L-arginine, D-arginine and steroid hormones. Hum Reprod (1995) 1.03
Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity. FEBS Lett (2001) 1.03
The in vivo role of bone marrow fibroblast-like stromal cells. Calcif Tissue Int (1996) 1.03
Human cathepsin X: A cysteine protease with unique carboxypeptidase activity. Biochemistry (1999) 1.03
Purification and characterization of dihydropyrimidine dehydrogenase from human liver. J Biol Chem (1992) 1.02
Immunohistochemical and in situ hybridization studies of gonadotropin releasing hormone (GnRH) and its receptor in rat digestive tract. Life Sci (2001) 1.02
Microfabrication technology: organized assembly of carbon nanotubes. Nature (2002) 1.02
Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy. Exp Clin Endocrinol Diabetes (2007) 1.01
Patient-reported quality of life early in dialysis treatment: effects associated with usual exercise activity. Nephrol Nurs J (2000) 1.01
Lethal outcome of uterine infection in pregnant but not in nonpregnant rats and increased death rate with inhibition of nitric oxide. Am J Reprod Immunol (1997) 1.01
Coordinate expression of NGF and alpha-smooth muscle actin mRNA and protein in cutaneous wound tissue of developing and adult rats. Cell Tissue Res (2000) 1.00
Effect of head-down-tilt bed rest and hypovolemia on dynamic regulation of heart rate and blood pressure. Am J Physiol Regul Integr Comp Physiol (2000) 1.00
Vagal cardiac function and arterial blood pressure stability. Am J Physiol Heart Circ Physiol (2001) 1.00
Ubiquitous induction of p53 in tumor cells by antisense inhibition of MDM2 expression. Mol Med (1999) 1.00